Multistar Paediatric Central Venous Catheter

Multistar: PUR Central Venous Catheter for Paediatric Patients

Multistar paediatric central venous catheter (CVC) is specially designed for the treatment of paediatric patients.

Designed for enhanced performance and safety. Multistar Incorporates the antimicrobials Rifampicin and Miconazole, to reduce the incidence of both catheter microbial colonisation and catheter related blood stream infections (CRIBSI’s).

A catheter for every patient with Multistar. Select the best size and length catheter to meet your patient’s requirements.

Vygon Code: N/A

Core Product Features

Specially designed for paediatric use

Multi-lumen and length options

Antimicrobial impregnation: Rifampicin & Miconazole

Reduce incidence of catheter microbial colonisation related CRBSI’s

For short term therapy: Up to 29 days

A-traumatic tip design, reducing vessel trauma

About Product

Multistar Paediatric Central Venous Catheter

Specially designed for even the most fragile of patients, the Multistar Paediatric CVC is puts treatment of children at the forefront.

Leading the Way in Paediatric Design for Central Venous Catheters

Select the right catheter for every patient with Vygon Multistar. Choose the best size CVC for the patients’ requirements, depending on their age, weight and therapy needs with a range of dilator length, catheter lengths and lumen numbers.

The Vygon Multistar CVC has multiple features specially designed with children in mind:

  • Antimicrobial incorporated Multistar clinically proven to reduce CRBSI
  • Two vessel dilator lengths for added safety on catheter insertion
  • Miniature size better suited to paediatric anatomy
  • Flexible tip protects the vessel walls
  • X-ray opaque catheter for confident tip placement
  • “J” Nitinol guidewire coated with Teflon for ultra-low resistance insertion
  • A choice of a short IV cannula or a high-performance echogenic introducer needle for catheterisation
  • Roberts clamps for secure one-handed line clamping


Enhanced Patient Safety with Antimicrobial Technology

The Multistar Paediatric CVC leads the way with antimicrobial technology for enhanced patient safety, by reducing the risk of catheter microbial colonisation and catheter related blood stream infections (CRIBSI’s).

Multistar uses the innovative combination of two active ingredients: Rifampicin and Miconazole, which are molecularly integrated into the polyurethane catheter material by using a patented multistep diffusion-controlled incorporation process. This combination leads to protection against a broad spectrum of microorganisms such as Staphylococci, Enterobacterial and candida. (2)

Rifampicin-Miconazole supersaturated CVCs have demonstrated the potential to prevent catheter-associated colonization, local infection and bloodstream infection even in long-term application.”(3)

Multistar is the innovative combination of two active ingredients: Rifampicin and Miconazole, chosen for their synergic properties:

  1. Efficacy on a large spectrum of microorganisms (3)
  2. Low risk of bacterial resistance development (3)

Clinically Proven

Multistar Paediatric CVC is backed up by a robust library of clinical studies. For more information on relevant clinical performance studies please contact a member of the Vygon team.

Training, Support and Education

Multistar Paediatric CVC is a core part of the critical care range of central venous access devices from Vygon UK. With access to dedicated training and education, combined with clinical tools, services and solutions to support healthcare professionals and patients.


  1. Scott-Warren, VL, Paediatric Vascular Access, BJA Education 15: 199-206, 2015
  2. Schierholz J, Nagelschmidt K, Nagelschmidt M, Lefering R, Yücel N, Beuth J, Antimicrobial central venous catheters in oncology: efficacy of a rifampicin-miconazole-releasing catheter, Anticancer Research 30: 1353-1358, 2010.
  3. Schierholz J, Summary of the issues associated with catheter related blood stream infections with special consideration given to catheters incorporating Rifampicin and Miconazole, 2011.
  4. Trieschmann, U. Udink ten F Cate. Sreeram, N. Central venous catheters in children and neonates – what is important?, Images in Paediatric Cardiology 9: 1-8, 2007.
  5. Rump A.F.E, Güttler K, König D.P, Yücel N, Korenkov M, Schierholz J, Pharmacokinetics of antimicrobial agents rifampicin and miconazole released from a loaded central venous, Journal of Hospital Infection 53; 129-135, 2003.

Presented in a rigid blister with label for traceability containing:

Component Description
Clamps Mini-Roberts
Guidewire Nitinol, PTFE, J-Shape, Ø 0,46 mm
Puncture Needle Echogenic introducer needle 21G
IV Cannula Short IV Cannula 22G
Scalpel Mini scalpel
Guidewire advancer

For more information, please refer to the Multistar IFU document.

Product Notes

  • Clean area in accordance with your hospital/departmental protocol
  • Catheters should be handled using strict aseptic-non-touch-techniques
  • Catheters introduced by a classic Seldinger technique into the internal jugular, subclavian or femoral veins (other access sites are also possible).
  • Indicated for short term therapy (29 days)
  • Multistar has a maximum infusion pressure of 21.74psi (1.5bar;1125mmHg)
  • The catheter is depth marked every centimetre, with a numerical marking every five centimetres

Product Compatibility
The Multistar Paediatric CVC are compatible with Vygon’s needle free connectors and octopus extensions. Please contact your Vygon representative to discuss.

UOI Units: Box

UOI: 5

Contains Latex: No

Contains DEHP: No

Pyrogen Free: Yes

Sterile Medical Device: Yes

Product Support

Supporting Documents Download:


Contact Us


There are currently no related events to this product.

Related Products


There are currently no related news articles to this product.